The TAG Team Is
Here to Help!
We work closely with our prospective clients to determine the best level of support based on
goals and current perceived gaps.
Whether it’s a phone consultation, online training or onsite visits – we’re here to help you!
​
​
800.401.2239
Watch the Video
Key Points
January 25, 2021
​​
-
In today’s Recommendations for Industry, we discuss the new administration’s federal strategy for COVID-19 worker protections.
-
On Thursday, The White House released a new Executive Order on Protecting Worker Health and Safety, which outlines actions the federal government must take to reduce the risk that workers may contract COVID-19 in the workplace. Actions include “partnering with state and local governments to better protect public employees; enforcing worker health and safety requirements; and pushing for additional resources to help employers protect employees.”
-
CDC has tweaked recommendations for the second dose of COVID-19 vaccinations (without data) to note that in extreme circumstances, the second dose can be another vaccine. TAG encourages employers to work with public health authorities to find a consistent and reliable source of vaccines so that this practice isn’t necessary.
-
Bharat Biotech’s BBV152 COVID-19 Phase 1 vaccine data “shows it is safe and immune-producing.”
-
A recent Kaiser Family Foundation poll shows that despite the push to get people vaccinated, 6 of 10 U.S. adults don’t know when they’ll get the COVID-19 vaccine; while 55% do not know where they will be able to receive one. However, the public is generally optimistic about the COVID-19 vaccination efforts. Read more of the report here.
-
Like other countries, the U.S., in order to slow the spread of the new COVID-19 strains, will soon place non-U.S. citizen travel restrictions to and from South Africa.
Recommendations for Industry
Watch for Federal Guidance COVID-19 Worker Protections
​
With the new administration moving forward quickly on COVID-19 response (as outlined in the 200-page National Strategy for the COVID-19 Response and Pandemic Preparedness issued last week, TAG is recommending that businesses keep a close eye on the actions and publications of the Biden Administration.)
The strategy includes plans for the federal government to undertake action to protect workers and issue stronger worker safety guidance. Among the items were an Executive Order Protecting Worker Health and Safety directing OSHA, in consultation with CDC, to:
-
Issue updated guidance on COVID-19 worker protections. This guidance is to be released within two weeks and provide a foundation for businesses to understand how to keep their workplaces safe.
-
Assess the need for emergency temporary standards. Immediately start work to determine whether to issue emergency temporary standards, which would create enforceable requirements to protect workers. If issued, this standard would direct employers to adopt plans to keep workers safe and healthy, and make clear how those standards are enforced by OSHA
Additionally, OSHA is to strengthen its enforcement efforts, launching a National Emphasis Program to focus enforcement resources on workplace violations that put the largest number of workers at serious risk. President Biden has also called on Congress to provide additional funds to bolster enforcement efforts.
With these expanded directives for worker safety, compounded by the continuing spread of the variants in the U.S., TAG recommends that all businesses continue all protections and assess their programs for true worker safety.
Although vaccines are rolling out, a new model by scientists at Columbia University is showing that regardless of vaccines, a premature relaxation of current risk mitigation measures would lead to a significant number of additional infections in the US before mid-summer. As the article states, “if precautions like working remotely, limiting travel, and wearing masks are relaxed too soon, it could mean millions (29 million) more infections and thousands more deaths.”
​
​
Source: New York Times
So, keep doing what you’re doing and keep an eye on the administration as well as the case trends in your geographic areas.
In Case You Missed It...
-
In Friday’s Recommendations for Industry, we explored President Biden’s new Federal Strategy – and a new TAG Vaccine Manual!
-
United States' President Joe Biden and the incoming administration has released the “National Strategy for The COVID-19 Response and Pandemic Preparedness”
-
President Biden is also encouraging “masking up” to reduce spread so that more businesses can be open. Masks will be required in airports, trains, intercity busses, etc. Additionally, the new Executive Order requires international travelers to show proof of having a negative COVID-19 test before coming to the U.S.
-
NPR reports that both the National Institutes of Health and the Infectious Diseases Society of America continue to update COVID-19 treatment guidelines, essentially giving a “scorecard on COVID-19 drugs”.
-
Nature reports that there is growing evidence “that some coronavirus variants could evade immune responses triggered by vaccines and previous infection”. However, this is still under investigation and “the picture is murky” as the results do not yet indicate the full importance.
-
From the emerging data, the B1117 variants “shouldn’t make a difference to the vaccine’s effectiveness but could as antibody levels wane over time.”
-
There may be a dampened response to the 501Y.V2 variant.
-
-
It is now believed that the B117 COVID-19 variant likely has been circulating in California and Florida since mid-November. There are currently 122 confirmed cases in 20 states.
-
In addition to TAG’s Vaccine Q&A, the New England Journal of Medicine has its own COVID-19 vaccine FAQ.
-
Although travel restrictions were set to be lifted by outgoing U.S. President Trump for 26 countries in the Schengen zone and Brazil, starting January 26th, incoming President Joe Biden is expected to block this order, due to the increasing rise in COVID-19 variants and coronavirus spread.
-
Kaiser Health reports that Black Americans are less likely to (and currently) not being vaccinated at the same rates as whites; due to lack of access and anti-vaccine sentiment.
Keep up to date with COVID-19:
​
Please send us any questions, comments, and/or concerns! We are happy to talk with you.
OR call us at 1-800-401-2239
Get the Insights & Guidance You Need!
Learn how TAG can help your company ensure food safety and brand protection.
Contact us today!